Wilson Sonsini Goodrich & Rosati advised GC Therapeutics on the transaction. GC Therapeutics (GCTx), a biopharmaceutical company, announced its launch and the completion of a $65...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Nohbo in the transaction. Nohbo announced the completion of its Series A funding round, led by Material Impact Fund. While the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Delve Bio in the transaction. Delve Bio announced it has debuted with $35 million in Series A financing led by Perceptive...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Investor Time BioVentures on the deal while WilmerHale represented Phantom Neuro. Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high...
You must be a Standard 1 Year member to access this content.
